<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>jmedicalcasereports</PublisherName>
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Volume 5; Issue 4</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>(Jul-Aug, 2024)</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>Analysis Of Hospital Data on Angioplasty and Infrainguinal Bypass for Chronic Critical Ischemia of The Lower Limbs in The Last 20 Years in Brazil</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>1</FirstPage>
      <LastPage>17</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Isabela Pereira de</FirstName>
          <LastName>Farias</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Maria Eliza</FirstName>
          <LastName>Marchi</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Matheus Oliveira</FirstName>
          <LastName>Figueiredo</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Raquel Dias</FirstName>
          <LastName>Cunha</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Gustavo Novaes</FirstName>
          <LastName>Lima</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Raimundo Nonato de Sousa</FirstName>
          <LastName>Andrade</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Wagner Ramos</FirstName>
          <LastName>Borges</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Chronic Limb Ischemia (CLI) is a severe stage of peripheral arterial disease characterized by reduced blood flow to the extremities, often leading to amputations and high morbidity and mortality rates. Treatment options include open revascularization or endovascular techniques such as angioplasty, which is less invasive but requires more frequent reinterventions. This observational and retrospective study compares hospital data for open revascularization and infrainguinal angioplasty in Brazil from 2004 to 2023, using SIH/SUS and DataSUS. The analysis included costs, mortality, length of stay, character of service, and demographic distribution of procedures. During this period, 114,417 angioplasty procedures and 47,502 open revascularizations were performed, with a total expenditure of $98.5 million. The number of deaths was 1,314 for angioplasty and 1,723 for revascularization, with mortality rates of 1.3% and 3.4%, respectively. The Northeast region stood out for having a higher ratio of angioplasty to open revascularization procedures.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Critical Limb Ischemia,Angioplasties,Revascularization,Treatment</Keywords>
      <URLs>
        <Abstract>https://www.jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=15287&amp;title=Analysis Of Hospital Data on Angioplasty and Infrainguinal Bypass for Chronic Critical Ischemia of The Lower Limbs in The Last 20 Years in Brazil</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Becker F, Robert-Ebadi H, Ricco JB, Setacci C, Cao P, de Donato G, Eckstein HH, De Rango P, Diehm N, Schmidli J, Teraa M, Moll FL, Dick F, Davies AH, Lepand;auml;ntalo M, Apelqvist J. Chapter I: Definitions, epidemiology, clinical presentation and prognosis. Eur J Vasc Endovasc Surg 2011; 42: S4-S12&#13;
&#13;
Bradbury AW, Moakes CA, Popplewell M, Meecham L, Bate GR, Kelly L, Chetter I, Diamantopoulos A, Ganeshan A, Hall J, Hobbs S, Houlind K, Jarrett H, Lockyer S, Malmstedt J, Patel JV, Patel S, Rashid ST, Saratzis A, Slinn G, Scott DJA, Zayed H, Deeks JJ; BASIL-2 Investigators. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet 2023; 401: 1798-1809.&#13;
&#13;
Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH; GVG Writing Group. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg 2019; 69: 3S-125S.e40&#13;
&#13;
Farber A. Chronic limb-threatening ischemia. N Engl J Med 2018; 379: 171-180.&#13;
&#13;
Farber A, Menard MT, Conte MS, Kaufman JA, Powell RJ, Choudhry NK, Hamza TH, Assmann SF, Creager MA, Cziraky MJ, Dake MD, Jaff MR, Reid D, Siami FS, Sopko G, White CJ, van Over M, Strong MB, Villarreal MF, McKean M, Azene E, Azarbal A, Barleben A, Chew DK, Clavijo LC, Douville Y, Findeiss L, Garg N, Gasper W, Giles KA, Goodney PP, Hawkins BM, Herman CR, Kalish JA, Koopmann MC, Laskowski IA, Mena-Hurtado C, Motaganahalli R, Rowe VL, Schanzer A, Schneider PA, Siracuse JJ, Venermo M, Rosenfield K; BEST-CLI Investigators. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. N Engl J Med 2022; 387: 2305-2316.&#13;
&#13;
Green JW, Wenzel RP. Postoperative wound infection: a controlled study of the increased duration of hospital stay and direct cost of hospitalization. Ann Surg 1977; 185: 264-268.&#13;
&#13;
Howard DP, Banerjee A, Fairhead JF, Hands L, Silver LE, Rothwell PM; Oxford Vascular Study. Population-Based Study of Incidence, Risk Factors, Outcome, and Prognosis of Ischemic Peripheral Arterial Events: Implications for Prevention. Circulation 2015; 132: 1805-1815.&#13;
&#13;
Kinlay S. Management of Critical Limb Ischemia. Circ Cardiovasc Interv 2016; 9: e001946.&#13;
&#13;
Menard MT, Farber A. The BEST-CLI trial: a multidisciplinary effort to assess whether surgical or endovascular therapy is better for patients with critical limb ischemia. Semin Vasc Surg 2014; 27: 82-84.&#13;
&#13;
Nehler MR, Duval S, Diao L, Annex BH, Hiatt WR, Rogers K, Zakharyan A, Hirsch AT. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg 2014; 60: 686-695.e2.&#13;
&#13;
Pereira HN, de Oliveira Santos RI, Uehara SC. Efeito da Estratand;eacute;gia Saand;uacute;de da Famand;iacute;lia na reduand;ccedil;and;atilde;o de internaand;ccedil;and;otilde;es por doenand;ccedil;as crand;ocirc;nicas nand;atilde;o transmissand;iacute;veis [Effect of the Family Health Strategy in reducing hospitalizations for chronic non-communicable diseases] [Efecto de la Estrategia de Salud Familiar en la reducciand;oacute;n de hospitalizaciones por enfermedades crand;oacute;nicas no transmisibles]. Revista Enfermagem UERJ 2020; 28: e49931.&#13;
&#13;
Popplewell MA, Davies H, Jarrett H, Bate G, Grant M, Patel S, Mehta S, Andronis L, Roberts T, Deeks J, Bradbury A; BASIL-2 Trial Investigators. Bypass versus angio plasty in severe ischaemia of the leg - 2 (BASIL-2) trial: study protocol for a randomised controlled trial. Trials 2016; 17: 11.&#13;
&#13;
Queiroz AB, Lopes JB, Marcos VC, Santos HM, Fidelis RJR, de Araand;uacute;jo Filho JS, Passos LCS. Physician-modified Stent Graft for Total Endovascular Aortic Arch Repair. Ann Vasc Surg 2021; 72: 667.e17-667.&#13;
&#13;
Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, Golzarian J, Gornik HL, Halperin JL, Jaff MR, Moneta GL, Olin JW, Stanley JC, White CJ, White JV, Zierler RE; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society for Vascular Medicine; Society for Vascular Surgery. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011; 58: 2020-2045.&#13;
&#13;
Schanzer A, Conte MS. Critical limb ischemia. Curr Treat Options Cardiovasc Med 2010; 12: 214-229.&#13;
&#13;
Spichler D, Miranda Jr F, Spichler ES, Franco LJ. Amputaand;ccedil;and;otilde;es maiores de membros inferiores por doenand;ccedil;a arterial perifand;eacute;rica e diabetes melito no municand;iacute;pio do Rio de Janeiro. Jornal Vascular Brasileiro 2020; 3: 111-122.&#13;
&#13;
Tunis SR, Bass EB, Steinberg EP. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease. N Engl J Med 1991; 325: 556-562.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>